High doses of intravenous protamine cause generalized vascular permeability changes in brain and other organs, and concomitant hypoproteinemia. The present investigations test the hypothesis that protamine has a dual action of both binding serum proteins and of undergoing absorptive-mediated transcytosis through microvascular endothelial barriers. Binding of albumin to protamine was demonstrated using equilibrium dialysis, and protamine was shown to selectively augment the uptake of albumin, but not sucrose, in isolated bovine or human brain capillaries. In contrast, the anionic macromolecule, dextran sulfate, resulted in an increased capillary uptake of both albumin and sucrose in vitro. The selective effects of protamine on albumin transport were also documented in vivo using an external organ technique; the intravenous injection of 1.5 mg/kg protamine resulted in a marked and selective influx of albumin into brain, heart, kidney, lung, and liver, and the increased albumin transport exceeded the increased sucrose uptake in some organs by an order of magnitude. The transcytosis of protamine through the cerebral microvascular barrier was documented with an internal carotid artery perfusion technique. In summary, these studies provide evidence for protamine-mediated vectorial transport of albumin through microvascular barriers in brain and other organs. (J. Clin. Invest. 1993. 92:2224-2229
Introduction
Protamine is a 7-kD arginine-rich cationic protein that is produced in high concentrations in spermatozoa, and which complexes DNA (1, 2) . Protamine infusion enhances the permeability of the cerebral endothelial wall, which makes up the blood-brain barrier (BBB)' in vivo, to large molecular weight proteins, such as albumin, or enzymes ofcomparable size, such VD, volume of distribution.
as horseradish peroxidase (HRP)' (3) (4) (5) . Protamine also increases vascular permeability to albumin in peripheral tissues (6) . The intravenous administration of a 40 mg/kg dose of protamine increases albumin uptake into organs and results in lowering of plasma albumin concentration with an increase in blood hematocrit (6) . Since endothelial glycocalyx anionic sites are believed to maintain vascular permeability (7), the mechanism ofthe protamine effect is hypothesized to involve a generalized increased vascular permeability in organs owing to neutralization of the endothelial anionic sites (6) . However, if protamine causes a general increase in vascular permeability, then the uptake of circulating small molecules should also be enhanced after the administration of toxic amounts of protamine. Although intracarotid protamine administration increases albumin uptake by brain, there is no increase in the cerebral uptake of glutamic acid, a circulating low molecular weight acidic amino acid (8) . The failure of protamine to increase the brain uptake of low molecular weight substances suggests alternative mechanisms for the action ofprotamine on microvascular beds. For example, protamine is known to complex proteins (9) . Also, protamine, a highly cationic protein ( 1, 2) , may undergo absorptive-mediated transcytosis through microvascular beds similar to other polycationic substances, such as histone (10) . Therefore, we hypothesize that the principle effect ofprotamine on vascular permeability in brain and other organs is to complex albumin and to cause a vector-mediated transport of albumin across microvascular beds, owing to the dual effects of protamine binding of albumin and protamine transport through endothelial barriers. The mechanism ofprotamine action on vascular permeability in vivo has clinical implications since high doses of protamine are used to neutralize heparin anticoagulant effects, for example, following extracorporeal perfusion in humans ( 11) .
The present studies assess the effects ofprotamine on vascular transport ofalbumin and a low molecular weight molecule, sucrose, in brain and other organs in vivo. Initially, a series of in vitro experiments were performed using isolated bovine or human brain capillaries. These Protein radiolabeling. Native rat serum albumin (Sigma catalog #A4538) was tritiated with 3H-NaBH4 to a specific activity of 1.6 'tCi/ jig and trichloracetic acid (TCA) precipitability of 99%, as described previously ( 12 ) . The same method was used to tritiate protamine to a specific activity of 0.076 iCi/Ag. Recombinant CD4 was radiolabeled to a specific activity of 1.9 ACi/Ag using 1251 and chloramine T as described previously ( 13) . Isolated bovine brain capillary uptake experiments. Fresh slaughterhouse bovine brain or autopsy human brain capillaries were isolated with a mechanical homogenization technique as described previously (12) . The brain capillary uptake of 3H-native rat serum albumin (nRSA) or [ '4C] sucrose was measured in vitro at 370C or 40C for up to 30 min of incubation in a final volume of 0.45 ml Ringer solution buffered to pH 7.4 with 10 mM Hepes. The following components were added to the incubation: 0-2 mg/ml protamine base, 0-50 mg/ ml bovine gamma globulin (byGlob), 0-50 mg/ml native BSA (nBSA), 0-100 Ag/ml dextran sulfate (either 5 kD or 500 kD molecular mass). The incubation was terminated by centrifugation at l0,OOOg and the capillary pellet was solubilized for double isotope liquid scintillation counting, and the percent capillary uptake ofeither 3H-nRSA or ['4C] sucrose was calculated. Endocytosis was measured at 37°C or 4°C using an acid wash technique, described previously ( 13) .
Equilibrium dialysis. The binding of [3H ] protamine to unlabeled nRSA was measured at 37°C over 4 h using equilibrium dialysis tubing with a 12 kD molecular mass cut-off, as described previously ( 14 sucrose by brain, heart, kidney, lung, and liver was measured in adult male Sprague-Dawley rats (250 g), anesthetized with ketamine (100 mg/kg), and xylazine (2 mg/kg) administered intraperitoneally, using an external organ technique described previously ( 15 ) . The tail artery was cannulated with PE-50 tubing and attached to a 3-cc syringe and 22-gauge needle that were fixed to a Harvard constant withdrawal pump. The experiment was initiated by the intravenous injection of0.2 ml Ringer solution buffered to pH 7.4 with 10 mM Hepes containing 75 ,uCi/ml of 3H-RSA and 25 ACi/ml [ '4C]sucrose, and 2 mg/ml of protamine. The protamine was added to the isotope solution just before injection to prevent the formation of aggregates. Blood was collected from the femoral artery at a constant rate for 5 min and the animal was then decapitated with extirpation of the five organs. The organ volume ofdistribution (VD) was calculated from the ratio of 14C-or 3H-DPM/g organ divided by the DPM/dl ofplasma. Division ofthe VD value by 5 min gives a value for clearance in Al/ min/g, since the use of the external organ technique allows for measurement of the integrated arterial plasma radioactivity ( 15 Protamine also enhanced the brain capillary uptake of other proteins such as 1251-recombinant CD4, and this effect was also inhibited by increasing concentrations of oy-globulin (Fig. 4) . The studies in Fig. 4 was not neutralized by dextran sulfate ( Table I ). The RSA uptake by brain capillaries was also selectively enhanced by other polycationic proteins such as histone or protamine sulfate, but not by poly-L-lysine (mol mass = 1-4 kD) at concentrations up to 1 mg/ml. Neutral dextran (150 kD) did not replicate the enhanced uptake of RSA or sucrose caused by the anionic dextran (data not shown).
The competition ofprotamine-mediated uptake of3H-RSA by either unlabeled y-globulin or unlabeled BSA (Fig. 2) Dextran Sulfate (jig ml -1) Mean±SEM (n = 3-4).
Discussion
The present studies are consistent with the following conclusions. First, protamine is transported through the BBB (Table  IV) , similar to other polycationic substances such as histone, which undergoes absorptive-mediated transcytosis through the BBB ( 10, 16). Second, protamine actively binds albumin (Table II) and selectively enhances the brain capillary uptake of albumin, but not sucrose, both in vitro (Figs. 1, 2, 3 ) and in vivo (Table III) . Third, the protamine effect is inhibited by physiologic concentrations of serum albumin or Sy-globulin with an ED50 of -1% plasma protein (Fig. 2) . Fourth, the polyanionic dextran sulfate augments brain capillary uptake of both serum albumin and sucrose in vitro (Fig. 5) , and this effect is blocked by protamine (Table I) and by serum protein (Table I) . Fifth, the protamine effect of enhanced vascular uptake is also seen for other proteins such as recombinant CD4 (Fig. 4) .
Cationization of proteins, in general, enhances cellular uptake of the protein ( 18, 19) . Cationization of albumin or IgG molecules enhances the cerebrovascular transport ofthese substances, and this process is believed to involve absorptive-mediated transcytosis through the brain capillary endothelium ( 16, 20) . Transcytosis of the polycationic proteins into brain interstitial fluid has been documented with thaw-mount autoradiography (20) , and other studies have shown that the glycocalyx on the lumenal side ofthe brain capillary endothelium contains sialic acid residues (21 ). The binding of cationized proteins such as cationized albumin to isolated brain capillaries in vitro is competitively inhibited by other polycationic peptides such as polylysine or protamine with an ED50 of -5 ,g/ml (22) . Therefore, the concentration of polylysine or protamine Mean±SEM (n = 3). * 1.5 mg/kg IV of salmon protamine base (Sigma grade 4, histone-free). *VD = volume of distribution determined at 5 min after intravenous injection of [3H]nRSA and ['4C]sucrose using the external organ technique. § VD = VD after protamine injection; VD = VD after control injection. 11 P < 0.025,1 P < 0.01 difference between VD after control and protamine injections.
that saturates BBB binding sites is about a log order lower than the concentration ofprotamine that saturates albumin binding sites (Table II) . In addition to binding anionic sites on brain capillary plasma membranes, protamine also binds serum proteins, such as albumin, with a KD ranging from 6-22 ,uM (Table II) . The binding of protamine by albumin correlates with other studies showing that proteins are complexed by protamine (9) . Previous reports have shown that the intravenous administration of protamine at a dose of 40 mg/kg results in a decrease in serum albumin that was attributed to a protamine-mediated generalized increase in vascular permeability (6) . However, protamine would be expected to undergo absorptive-mediated transcytosis across the capillary endothelia in peripheral organs similar to that demonstrated here for brain (Table IV) . If the protamine that is transcytosed through the endothelia of peripheral capillaries also binds circulating albumin, then a substantial reduction in serum albumin concentration may occur on the basis ofthis mechanism ofvectorial transport. For example, based on the KD of albumin binding of protamine ( Table   Table IV (Table III) . However, there is no statistically significant change in the [ '4C ] sucrose VD in either brain or heart following intravenous administration ofprotamine (Table III) . This lack of change in BBB permeability to the low molecular weight sucrose parallels other observations showing no change in BBB transport of glutamic acid following protamine administration (8) . The failure to observe changes in BBB permeability to sucrose following intravenous administration of protamine may be due to the protective effects ofserum protein binding of protamine. For example, the intracarotid infusion of relatively low concentrations of protamine ( 13 , Finally, the present studies demonstrate protamine also enhances the brain capillary uptake of other proteins such as recombinant CD4. This suggests that protamine may mediate the trans-capillary transport oftherapeutic proteins by virtue of its dual capacity to both bind the protein and initiate transcytosis through the capillary endothelium. High or even moderate concentrations of protamine may cause toxicity owing to a generalized increase in cerebrovascular permeability as demonstrated by the elevated sucrose transport observed with the internal carotid artery perfusion studies (Table IV) . However, low doses ofprotamine are not toxic, as protamine is a constituent of insulin preparations, which are administered to diabetic patients daily for many years (24) . Such low concentrations of protamine would not be expected to have any generalized effects on vascular permeability, but may mediate the trans-capillary transport of peptides or proteins that are bound to protamine. This mechanism may explain the augmentation of adrenocorticotropic hormone (ACTH) secretion caused by the co-administration of protamine and melanin concentrating hormone (MCH) into the carotid artery; protamine facilitates BBB transport of MCH, which increases pituitary ACTH release via a central mechanism (25). The limitation of using polycationic proteins such as protamine or histone (10) to deliver peptides such as MCH or CD4 to brain is the low bioavailability of the drug, owing to rapid clearance from blood (26) . For example, the distribution tl/2 of intravenous histone is less than 1 min in rats (10) . The major organs responsible for the rapid clearance of polycationic proteins are lung and liver, and to a lesser extent, kidney ( 10) . Moreover, these organs are the principle sites ofalbumin clearance following intravenous protamine administration (Table III) . This correlation corroborates the hypothesis that the major mechanism underlying the increased uptake of albumin by organs is the vectorial delivery of the plasma protein mediated by protamine.
In summary, these studies provide evidence for dual effects of protamine on vascular permeability. First, protamine may cause a generalized increase in vascular permeability, particularly following carotid artery infusion (Table IV and references  3 -5) . This generalized increase in vascular permeability may involve opening of interendothelial junctions and allow for transport of either low molecular weight solutes, e.g., sucrose, or plasma protein via a paracellular pathway. A second mechanism of protamine action is the selective increase in vascular permeability to proteins that are also bound by protamine.
This vectorial transfer ofprotamine-protein complexes appears to be the principal mechanism following intravenous administration of protamine. The uptake of albumin greatly exceeds the uptake of sucrose in liver, lung, and kidney (Table III) , and these observations are explicable within the context of a model that allows for vectorial transcellular movement across capillary endothelial barriers of protamine-albumin complexes.
